---
title: "投資者警報：Pomerantz 律師事務所代表葛蘭素史克公司的投資者進行索賠調查 - GSK"
description: "Pomerantz 律師事務所正在代表 GSK plc 投資者調查有關該公司及其高管可能存在的證券欺詐或非法商業行為的索賠。這一調查是由於 2025 年 7 月 17 日 FDA 顧問委員會對 GSK 的 Blenrep 的利益/風險評估投票反對，導致其 ADR 價格下跌 4.73%。鼓勵投資者聯繫該事務所以獲取有關加入集體訴訟的更多信息"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/252340919.md"
published_at: "2025-08-09T16:05:34.000Z"
---

# 投資者警報：Pomerantz 律師事務所代表葛蘭素史克公司的投資者進行索賠調查 - GSK

> Pomerantz 律師事務所正在代表 GSK plc 投資者調查有關該公司及其高管可能存在的證券欺詐或非法商業行為的索賠。這一調查是由於 2025 年 7 月 17 日 FDA 顧問委員會對 GSK 的 Blenrep 的利益/風險評估投票反對，導致其 ADR 價格下跌 4.73%。鼓勵投資者聯繫該事務所以獲取有關加入集體訴訟的更多信息

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GSK plc (“GSK” or the “Company”) (NYSE: GSK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The investigation concerns whether GSK and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

**\[Click here for information about joining the class action\]**

On July 17, 2025, GSK issued a press release announcing “that the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of *Blenrep* (belantamab mafodotin-blmf) combinations.”

On this news, GSK’s American Depositary Receipt (“ADR”) price fell $1.81 per share, or 4.73%, to close at $36.47 per share on July 17, 2025.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, London, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

**CONTACT:  
**Danielle Peyton  
Pomerantz LLP  
dpeyton@pomlaw.com  
646-581-9980 ext. 7980

### Related Stocks

- [GSK.UK - 葛蘭素史克](https://longbridge.com/zh-HK/quote/GSK.UK.md)
- [GSK.US - 葛蘭素史克](https://longbridge.com/zh-HK/quote/GSK.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| OpenClaw 之父爆猛料：Meta 和 OpenAI 跪着抢人，小扎亲自求收购 | 在一场重磅播客访谈中，OpenClaw 之父 Peter Steinberger 透露，Meta 的扎克伯格和 OpenAI 的 Sam Altman 都在积极拉拢他，甚至扎克伯格亲自表示对 OpenClaw 的赞赏。两大科技巨头同时争抢人 | [Link](https://longbridge.com/zh-HK/news/275962731.md) |
| OPEC 月报：1 月全球产油盟国产量大幅下滑，维持今明两年需求预测不变 | 受哈萨克斯坦、委内瑞拉及伊朗供应中断影响，OPEC+ 1 月日均产量环比锐减 43.9 万桶至 4244.8 万桶，远超市场预期。其中哈萨克斯坦因 Tengiz 油田停产贡献了过半降幅，但目前该油田已开始复产，供应冲击或为短期。尽管产量骤降 | [Link](https://longbridge.com/zh-HK/news/275613183.md) |
| 马斯克情人节 “挥刀自宫”！为了一己私利，还是造福全人类？ | 马斯克宣布特斯拉将在情人节停售 FSD，改为 199 美元/月的会员模式，永久使用权需在此之前支付 8000 美元。特斯拉 AI5 芯片设计接近完成，算力提升 5 倍，目标是降低成本和功耗，支持未来的无人驾驶出租车和机器人。特斯拉还计划建设 | [Link](https://longbridge.com/zh-HK/news/275680196.md) |
| 英格索兰｜8-K：2025 财年 Q4 营收 20.91 亿美元超过预期 |  | [Link](https://longbridge.com/zh-HK/news/275811467.md) |
| 莫霍克工业｜8-K：2025 财年 Q4 营收 27 亿美元超过预期 |  | [Link](https://longbridge.com/zh-HK/news/275810669.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。